MarketInOut Stock Screener Log In | Sign Up

Purple Biotech Ltd ADR

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Purple Biotech Ltd ADR stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1.5 mln
Float1.62 mln
Earnings Date11/13/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

78 / 100
Strongly outperforming

Debt / Equity

0.01
Debt-free

ROE

-127
Deeply negative

ROA

-103
Deeply negative

Business Description

Purple Biotech Ltd. is an Israel-based clinical-stage biopharmaceutical company working to help cancer patients whose tumors resist treatment or evade the immune system. The company is advancing several experimental therapies, including two drugs currently in Phase 2 trials targeting pancreatic cancer, head and neck cancer, and colorectal cancer, as well as an early-stage program aimed at stimulating the immune system to attack tumors. Purple Biotech works alongside Bristol Myers Squibb to test one of its key treatments in combination with a widely used immunotherapy drug.

Key Fundamentals

EPS-47.64
ROE-127
ROIC-40.01
ROA-103
Interest Cover-116
EBITDA, mln-23.48
EV / EBITDA-0.04
EV / EBIT-0.04

Quote Details

Last 1.17
Change 0.08 (7.34%)
Open 1.09
Volume 41,575
Turnover 48,643
Average Volume 23,360

Financial Ratios

Leverage Ratio1.15
Current Ratio3.70
Price / Book0.97
Debt / Equity0.01

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio0.01
Short % of Float1.11

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.33% 92 / 100   
1 Month -23.03% 16 / 100   
2 Months -18.75% 23 / 100   
6 Months -72.14% 6 / 100   
1 Year -88.96% 6 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog